EXCLUSIVE U.S. opens criminal probe into alleged lapses at Eli Lilly plant

The U.S. Justice Department has launched a criminal investigation into Eli Lilly and Co (LLY.N) focused on alleged manufacturing irregularities and records tampering at a factory in Branchburg, New Jersey, that produces the pharmaceutical giant’s COVID-19 therapy and other drugs, three people familiar with the matter said.

Inside the race to find a COVID-19 treatment pill

In early 2020, as a new deadly coronavirus began spreading around the world, Pfizer Inc (PFE.N) assembled what it called a “SWAT team” of scientists and chemists to identify a potential treatment to fight COVID-19.